CMC121 was found to alleviate cognitive loss by modulating lipid metabolism and reducing inflammation and lipid peroxidation via inhibiting the fatty acid synthase in vitro and in vivo models of AD (Ates et al., 2020). Here, FASN is linked to Alzheimer disease.